Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Surwit

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 1, 1985
Endogenous opiate peptides, stress reactivity, and risk for hypertensionJ A McCubbin, R S Surwit, R B Williams
Journal of Applied Behavior Analysis|January 1, 1980
Biofeedback, autogenic training, and progressive relaxation in the treatment of Raynaud's disease: a comparative studyF J Keefe, R S Surwit, R N Pilon
Journal of Behavioral Medicine|September 1, 1978
Behavioral treatment of Raynaud's diseaseR S Surwit, R N Pilon, C H Fenton
Journal of Behavioral Medicine|December 1, 1979
A 1-year follow-up of Raynaud's patients treated with behavioral therapy techniquesF J Keefe, R S Surwit, R N Pilon
Life Sciences|January 1, 1995
Glipizide stimulates sympathetic outflow in diabetes-prone miceC M Kuhn, R S Surwit, M N Feinglos
Psychosomatic Medicine|January 1, 1988
Opioid dysfunction and risk for hypertension: naloxone and blood pressure responses during different types of stressJ A McCubbin, R S Surwit, R B Williams
The American Psychologist|March 1, 1983
Diabetes and behavior. A paradigm for health psychologyR S Surwit, M N Feinglos, A W Scovern
Diabetes|September 1, 1997
Low plasma leptin in response to dietary fat in diabetes- and obesity-prone miceR S Surwit, A E Petro, P Parekh, et al.
Diabetes Care|June 7, 2000
Is there a glycemic threshold for impaired autonomic control?L L Watkins, R S Surwit, P Grossman, et al.
Endocrinology|January 1, 1997
Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in miceS Collins, K W Daniel, A E Petro, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Hypertension (Dallas, Tex. : 1979)|September 1, 1985
Endogenous opiate peptides, stress reactivity, and risk for hypertensionJ A McCubbin, R S Surwit, R B Williams
Journal of Applied Behavior Analysis|January 1, 1980
Biofeedback, autogenic training, and progressive relaxation in the treatment of Raynaud's disease: a comparative studyF J Keefe, R S Surwit, R N Pilon
Journal of Behavioral Medicine|September 1, 1978
Behavioral treatment of Raynaud's diseaseR S Surwit, R N Pilon, C H Fenton
Journal of Behavioral Medicine|December 1, 1979
A 1-year follow-up of Raynaud's patients treated with behavioral therapy techniquesF J Keefe, R S Surwit, R N Pilon
Life Sciences|January 1, 1995
Glipizide stimulates sympathetic outflow in diabetes-prone miceC M Kuhn, R S Surwit, M N Feinglos
Psychosomatic Medicine|January 1, 1988
Opioid dysfunction and risk for hypertension: naloxone and blood pressure responses during different types of stressJ A McCubbin, R S Surwit, R B Williams
The American Psychologist|March 1, 1983
Diabetes and behavior. A paradigm for health psychologyR S Surwit, M N Feinglos, A W Scovern
Diabetes|September 1, 1997
Low plasma leptin in response to dietary fat in diabetes- and obesity-prone miceR S Surwit, A E Petro, P Parekh, et al.
Diabetes Care|June 7, 2000
Is there a glycemic threshold for impaired autonomic control?L L Watkins, R S Surwit, P Grossman, et al.
Endocrinology|January 1, 1997
Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in miceS Collins, K W Daniel, A E Petro, et al.
Pageof 9